HTG Transcriptome Panel - Early Adopter Program

We thank our early adopters for being our customers, advocates and helping us shape the future of gene expression profiling with the HTG Transcriptome Panel. We are grateful for your support and realize that you are the essential part of what powers innovation and breakthroughs.

    The University of Texas 
    MD Anderson Cancer Center

Saint John’s 
Cancer Institute

Duke University 
Medical Center



 
 

Fundación Instituto
Valenciano de Oncologia

 

Tyrolpath Obrist
Brunhuber GmbH

Featured Publication

Cross-platform comparison of immune-related gene expression to assess intra tumor immune response following cancer immunotherapy

Two commonly used targeted gene expression profiling platforms are compared in this  article.
 

 READ PUBLICATION

News & Events

HTG Receives First Commercial Orders for its Planned HTG Transcriptome Panel and Announces the Signing of Two European Early Adopter Program Agreements

TUCSON, Ariz. , June 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome Panel and has signed

Keep Reading

HTG Completes Product Design Lock for its Planned Transcriptome Panel and Announces the Signing of the Three Early Adopter Program Collaboration Agreements

TUCSON, Ariz. , June 14, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has completed product design lock for the HTG Transcriptome Panel and announced three Early Adopter

Keep Reading

HTG EdgeSeq Technology Highlighted in Several Posters Being Presented at the American Society of Clinical Oncology 2021 Virtual Conference

TUCSON, Ariz. , May 24, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its HTG EdgeSeq technology is highlighted in several posters being presented at the American Society of

Keep Reading

HTG Molecular Diagnostics Reports First Quarter 2021 Results and Provides a Corporate Update

Call scheduled for today, May 13, at 4:30 pm ET TUCSON, Ariz. , May 13, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31,

Keep Reading

HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13

TUCSON, Ariz. , May 04, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the quarter ended March 31, 2021 after the market close on Thursday,

Keep Reading

Careers at HTG

At HTG Molecular Diagnostics, Inc., we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

Featured Positions

New Careers

Project Coordinator - Commercial Services Lab

See All Careers


Resources

Find product information, specifications and gene lists here. 

Case Studies

Brochures

Gene Lists

Product Sheets

Tech Notes

Safety Data Sheets

Videos


Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars

Peer Reviewed Publications

Editorials

Reviews


Support

Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or panels. 

Product Launch Files

User Manuals RUO

User Manuals CE-IVD

Package Inserts RUO

Package Inserts CE-IVD

Training Modules RUO

Training Modules CE-IVD

Deployer Software Downloads

HTG Software Downloads

Page last updated June 23, 2021

Ready to get started?

HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.

Get in Touch